Oerlikon Leybold Vacuum announced the opening of its new production facility in Tianjin, China. The new facility is the third substantial expansion of the existing plant. With this extension, Oerlikon Leybold Vacuum is able to move additional product lines and customized solutions into Chinese manufacturing. Link: Click Here

Transocean Announces Pricing of Share Offering. Transocean Ltd. (SIX: RIGN) today announced that it has priced its previously-announced public offering of 26,000,000 of its shares at a public offering price of U.S. $40.50 per share, or 37.32 Swiss francs per share at an exchange rate of 0.9215 Swiss francs per U.S. $1.00. Link: Click Here

Feintool reports a successful financial year. Group-wide, the order situation developed well: orders received rose by 8%* to CHF 415 million and the orders backlog by 26% to CHF 188 million. At CHF 360 million, sales exceeded the previous year's figure by 7%. Link: Click Here

Swiss Prime Site is divesting the Volkiland shopping centre in Volketswil as well as the nearby "Under Höh" commercial property as at 1 December 2011. The sales proceeds of CHF 280 million will result in gross profit of roughly CHF 77 million for the company. Link: Click Here

Roche (SIX: RO, ROG) today announced that it will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer, at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) December 6-10 2011. Link: Click Here

GenX Mobile teams with u-blox for 3G HSPA and CDMA Vehicle Tracking Platforms. GenX Mobile, Inc. introduces its new 3G HSPA product line for the vehicle tracking market. At the core of the platform is u-blox’ compact LISA wireless module series, the world’s smallest 3G modem family, and a u-blox 6 GPS receiver module. Link: Click Here

Inficon Holding AG has decided to change its financial reporting standard from US GAAP to Swiss GAAP FER effective January 1, 2012. INFICON has submitted a request to SIX Swiss Exchange, asking to migrate the listing of its shares from the regulatory Main Standard to the Domestic Standard. Link: Click Here

Basilea Pharmaceutica Ltd. (SIX:BSLN) shareholders elect additional members to the board of directors. Today the shareholders of Basilea elected Dr. Thomas M. Rinderknecht, Mr. Domenico Scala and Dr. Thomas Werner as additional members to the board of directors for a term of three years each. Link: Click Here